Peter A. Harris

Virus-directed, enzyme prodrug therapy with nitroimidazole reductase: a phase I and pharmacokinetic study of its prodrug, CB1954.

G Chung-Faye, Daniel H. Palmer, David A. Anderson et al. · PubMed · 2001 · 137 citations

Pharmacokinetic Study, Pathology, Pharmacotherapy +19

Virus-Directed Enzyme Prodrug Therapy: Intratumoral Administration of a Replication-Deficient Adenovirus Encoding Nitroreductase to Patients With Resectable Liver Cancer

Daniel H. Palmer, Vivien Mautner, Darius F. Mirza et al. · Journal of Clinical Oncology · 2004 · 129 citations · Full text

Hypoxia-Selective Targeting by the Bioreductive Prodrug AQ4N in Patients with Solid Tumors: Results of a Phase I Study

Mark R. Albertella, Paul M. Loadman, Philip H. Jones et al. · Clinical Cancer Research · 2008 · 125 citations

Randomized Trial of the Combination of Lomeguatrib and Temozolomide Compared With Temozolomide Alone in Chemotherapy Naive Patients With Metastatic Cutaneous Melanoma

Malcolm Ranson, Peter Hersey, D.M. Thompson et al. · Journal of Clinical Oncology · 2007 · 110 citations

Enzyme purification using temperature-induced phase formation.

Peter A. Harris, Gunnar Karlström, Folke Tjerneld · PubMed · 1991 · 74 citations